Baiyang Pharmaceutical Group signed an agreement with Peking University Hospital. On December 12, Baiyang Pharmaceutical Group signed a cooperation agreement with Peking University No.1 Hospital, and obtained the exclusive right to patent, clinical development and registration, production and marketing of "targeted integrin small molecule inhibitor" in Peking University Hospital.Analysis: The initial application data in the United States unexpectedly rose, and the number of initial jobless claims in the United States unexpectedly rose last week. The number of people receiving unemployment benefits continued to increase at the end of November compared with the beginning of the year, due to the cooling of labor demand. The US Department of Labor announced on Thursday that as of the week of December 7, the number of initial jobless claims increased by 17,000 to 242,000 after seasonal adjustment. Economists had expected that the number of initial jobless claims last week was only 220,000. The jump in initial jobless claims last week may reflect the fluctuation after the Thanksgiving holiday, but it may not mark a sudden change in the job market. The number of initial jobless claims may still fluctuate in the next few weeks, which may make it difficult to understand the job market clearly.Deutsche Bank: MARCUS CHROMIK was appointed as Chief Risk Officer.
Russia said it would not make concessions on the Ukrainian issue and hoped to make contact with the US. Russian Foreign Ministry spokesman Zacharova said at a regular press conference on the 11th local time that Russia would not make concessions on the Ukrainian issue in response to the negotiation proposal put forward by US President-elect Trump on the 8th, and hoped to make contact with the US, but so far it has not received any "serious suggestions" from the team of US President-elect Trump. Zacharova also said that the recent statement of Ukrainian President Zelensky showed that "achieving peace is not a priority for Ukraine". Zelensky reiterated a few days ago that Uzbekistan will not sign any kind of peace agreement without security guarantee.European Central Bank President Lagarde: Potential inflation and inflation continue to return to the target in the same direction.The concept of cryptocurrency in US stocks strengthened collectively at the beginning of the session, with Hut 8 and Riot Platforms rising by more than 8%, Bitdeer rising by more than 6%, TeraWulf and CleanSpark rising by more than 3%. In the news, US President-elect Trump announced that he would do some great things in the field of cryptocurrency.
Analysts commented on the ECB's interest rate cut, and Christiansen, an analyst at Danske Bank, said that the restrictive hawkish tendency in the ECB's policy has been eliminated. However, there is no indication that the bank may cut interest rates sharply, and there is no indication that the terminal interest rate will fall. Carsten Brzeski, head of international macro business in the Netherlands, said that the European Central Bank decided to play it safe today and cut interest rates by 25 basis points. No more mention of "restrictive" monetary policy, which means there will be more interest rate cuts in the future. Analyst Randow said that the change in the wording of the European Central Bank indicates that the ECB Committee has discussed the neutral interest rate. Otherwise, how can they decide what is restrictive and what is lenient? I am curious about what Lagarde will say next. Vassilis, a foreign exchange strategist, said that the euro fell to a new low because the European Central Bank gave up the "restrictive policy" part of the statement, but this does not mean that the policy language is completely dovish. Bonds in the euro zone are in a moderate trend.European Central Bank President Lagarde: National elections have also led to their own uncertainties.European Central Bank President Lagarde: The economy will strengthen over time.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14